Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 20.03% Profit

May 03, 2023
On January 11, 2023, QuantWave issued a forecast signal for ELI LILLY AND COMPANY stock, predicting a long position with a price target of $423.98. This forecast proved to be highly accurate as the target was reached on May 3, 2023, resulting in a profit of 20.03% for investors.

The stock price of ELI LILLY AND COMPANY at the time of the signal was $353.24, indicating a significant increase to reach the forecasted target. This success highlights the effectiveness of QuantWave's analytics in providing actionable insights for traders and investors in the financial markets.

Several factors may have contributed to the movement of ELI LILLY AND COMPANY stock, including positive developments in the company's product pipeline, strong financial performance, and overall market sentiment towards the healthcare sector. By leveraging QuantWave's forecasting capabilities, investors were able to capitalize on these market dynamics and achieve profitable outcomes.

QuantWave is a leading automated forecasting platform that offers forecasts for a wide range of stocks, presenting opportunities for users to potentially generate profits in their investment activities. For those interested in delving deeper into QuantWave's investment strategy, QuantSchool provides comprehensive educational resources on how to effectively utilize the forecasting system to generate consistent income in the financial markets.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

UNHJuly 17, 2024UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast with 8.38% Profit  ~1 min.

UNITEDHEALTH GROUP INCORPORATED has successfully reached the price target forecast provided by QuantWave on July 17, 2024....

UNHJuly 30, 2024UNITEDHEALTH GROUP INCORPORATED Hits 7.86% Profit Target as Forecasted by QuantWave  ~2 min.

UNITEDHEALTH GROUP INCORPORATED (NYSE: UNH) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 7.86% for investors....

ABTOctober 12, 2023ABBOTT LABORATORIES Hits Forecast Price Target with 10.91% Profit, Confirming QuantWave's Accuracy  ~2 min.

Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors....

LLYMay 3, 2023ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 19.83% Profit  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target forecast set by QuantWave, resulting in a profit of 19.83%. The forecast signal was issued on December 9, 2022, with a price of 353....

BMYNovember 11, 2024BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 13.38% Profit  ~1 min.

On October 22, 2024, QuantWave issued a forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price target of $58.53, predicting a long position. The stock was trading at $51....